NMS·Healthcare·$1.5B·#154 / 520 in Healthcare
NBTX Nanobiotix S.A.
58SPECULATIVE
CATEGORY BREAKDOWN
GROWTH100
QUALITY40
STABILITY79
VALUATION0
GOVERNANCE29
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+355.3%
100
> 50% strong
Gross Margin
Revenue retained after direct costs
N/A
0
> 50% strong
Cash Runway
Months of cash at current burn rate
19 months
68
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
-112.8%
100
< 25% strong
Price / Sales
Market cap relative to trailing revenue
45.8x
0
< 3x strong
Rule of 40
Growth rate plus operating margin
319
100
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
0.0%
0
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+2.3%
86
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE NBTX WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when NBTX's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.